Investor alert: law offices of howard g. smith announces investigation of abeona therapeutics inc. (abeo) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith announces an investigation on behalf of abeona therapeutics inc. (“abeona” or the “company”) (nasdaq: abeo) investors concerning the company's possible violations of federal securities laws. on april 22, 2024, abeona disclosed that it had received a complete response letter (“crl”) from the fda regarding its recessive dystrophic epidermolysis bullosa treatment, pz-cel, stating that “the fda noted that certain additional information.
ABEO Ratings Summary
ABEO Quant Ranking